As Viatris, we are compliant with the AMRIA Antibiotic Manufacturing Standard for our own operations and committed to implementing it across our external supply chain. All applicable Viatris manufacturing locations with antibiotic production have been internally assessed and adhere to the AMRIA Antibiotic Manufacturing Standard, including meeting the PNEC (RQ<1) as calculated by mass balance.
Milestone Certification for Reducing the Risk of AMR in Manufacturing
Five sites in Viatris’ network in Australia, Germany, India and Ireland, have earned the British Standards Institute (BSI) Kitemark Certification under the AMRIA Manufacturing Standard for meeting standards aimed at minimizing the environmental risk of AMR. The Antibiotic Manufacturing Standard, published by AMRIA and facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure that their antibiotics are made responsibly, helping to minimize the risk of AMR in the environment. These certifications provide independent, third-party assurance and demonstrate that antibiotic residue emissions from solid and liquid waste streams are effectively controlled during manufacturing.